420 related articles for article (PubMed ID: 26141703)
1. Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia.
Abeti R; Uzun E; Renganathan I; Honda T; Pook MA; Giunti P
Pharmacol Res; 2015 Sep; 99():344-50. PubMed ID: 26141703
[TBL] [Abstract][Full Text] [Related]
2. 'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'.
Abeti R; Parkinson MH; Hargreaves IP; Angelova PR; Sandi C; Pook MA; Giunti P; Abramov AY
Cell Death Dis; 2016 May; 7(5):e2237. PubMed ID: 27228352
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
[TBL] [Abstract][Full Text] [Related]
4. Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich's Ataxia Models.
Abeti R; Baccaro A; Esteras N; Giunti P
Front Cell Neurosci; 2018; 12():188. PubMed ID: 30065630
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB
J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.
Khdour OM; Bandyopadhyay I; Chowdhury SR; Visavadiya NP; Hecht SM
Bioorg Med Chem; 2018 Jul; 26(12):3359-3369. PubMed ID: 29773347
[TBL] [Abstract][Full Text] [Related]
7. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
[TBL] [Abstract][Full Text] [Related]
8. Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
Soriano S; Llorens JV; Blanco-Sobero L; Gutiérrez L; Calap-Quintana P; Morales MP; Moltó MD; Martínez-Sebastián MJ
Gene; 2013 Jun; 521(2):274-81. PubMed ID: 23542074
[TBL] [Abstract][Full Text] [Related]
9. Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model.
Shan Y; Schoenfeld RA; Hayashi G; Napoli E; Akiyama T; Iodi Carstens M; Carstens EE; Pook MA; Cortopassi GA
Antioxid Redox Signal; 2013 Nov; 19(13):1481-93. PubMed ID: 23350650
[TBL] [Abstract][Full Text] [Related]
10. Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts.
Richardson TE; Yu AE; Wen Y; Yang SH; Simpkins JW
PLoS One; 2012; 7(4):e34600. PubMed ID: 22509330
[TBL] [Abstract][Full Text] [Related]
11. Altered lipid metabolism in a Drosophila model of Friedreich's ataxia.
Navarro JA; Ohmann E; Sanchez D; Botella JA; Liebisch G; Moltó MD; Ganfornina MD; Schmitz G; Schneuwly S
Hum Mol Genet; 2010 Jul; 19(14):2828-40. PubMed ID: 20460268
[TBL] [Abstract][Full Text] [Related]
12. Changes in mitochondrial glutathione levels and protein thiol oxidation in ∆yfh1 yeast cells and the lymphoblasts of patients with Friedreich's ataxia.
Bulteau AL; Planamente S; Jornea L; Dur A; Lesuisse E; Camadro JM; Auchère F
Biochim Biophys Acta; 2012 Feb; 1822(2):212-25. PubMed ID: 22200491
[TBL] [Abstract][Full Text] [Related]
13. Friedreich's ataxia: from disease mechanisms to therapeutic interventions.
Lodi R; Tonon C; Calabrese V; Schapira AH
Antioxid Redox Signal; 2006; 8(3-4):438-43. PubMed ID: 16677089
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction in friedreich's ataxia.
Lodi R; Taylor DJ; Schapira AH
Biol Signals Recept; 2001; 10(3-4):263-70. PubMed ID: 11351132
[TBL] [Abstract][Full Text] [Related]
15. Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia.
Chiang S; Kovacevic Z; Sahni S; Lane DJ; Merlot AM; Kalinowski DS; Huang ML; Richardson DR
Clin Sci (Lond); 2016 Jun; 130(11):853-70. PubMed ID: 27129098
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial pathophysiology in Friedreich's ataxia.
González-Cabo P; Palau F
J Neurochem; 2013 Aug; 126 Suppl 1():53-64. PubMed ID: 23859341
[TBL] [Abstract][Full Text] [Related]
17. Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review).
Palau F
Int J Mol Med; 2001 Jun; 7(6):581-9. PubMed ID: 11351269
[TBL] [Abstract][Full Text] [Related]
18. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.
Wong A; Yang J; Cavadini P; Gellera C; Lonnerdal B; Taroni F; Cortopassi G
Hum Mol Genet; 1999 Mar; 8(3):425-30. PubMed ID: 9949201
[TBL] [Abstract][Full Text] [Related]
19. Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia.
Lin H; Magrane J; Rattelle A; Stepanova A; Galkin A; Clark EM; Dong YN; Halawani SM; Lynch DR
Dis Model Mech; 2017 Nov; 10(11):1343-1352. PubMed ID: 29125827
[TBL] [Abstract][Full Text] [Related]
20. Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids.
Cotticelli MG; Crabbe AM; Wilson RB; Shchepinov MS
Redox Biol; 2013; 1(1):398-404. PubMed ID: 25499576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
